NASDAQ
2.41USD
+0.12 (+5.24%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
172.4M
P/E
—
EPS
—
Beta
0.94
52W range
1.7-3.72
Day range
2.32–2.44
Open
2.32
Prev close
2.29
Volume
531.2K
Avg volume
692.7K
Dividend
0.00
IPO
2020-07-10
https://www.globenewswire.com/news-release/2026/07/23/3331872/0/en/Cyllene-Therapeutics-Expands-Leadership-Team-to-Support-Corporate-Growth-and-Clinical-Product-Development.html · 7/23/2026+0.00
https://www.globenewswire.com/news-release/2026/06/26/3318219/0/en/Nkarta-to-Participate-in-H-C-Wainwright-4th-Annual-Cell-Therapy-Virtual-Conference.html · 6/26/2026+0.20
https://www.globenewswire.com/news-release/2026/03/25/3262553/0/en/Nkarta-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Corporate-Highlights.html · 3/25/2026+0.60
https://www.globenewswire.com/news-release/2025/10/22/3171260/0/en/Nkarta-Announces-Poster-Presentation-at-Upcoming-American-College-of-Rheumatology-ACR-Convergence-Meeting.html · 10/22/2025+0.60
Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. Its lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. The company has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
